Abstract
Pentosidine is a highly fluorescent advanced glycation end product (AGE) and crosslink derived from one molecule of arginine and one of lysine bridged in an imidazo-pyridinium structure (Fig. 1). It was first isolated from articular cartilage by Sell and Monnier (1), and has now been detected and quantified in a variety of human and animal tissues, including skin and kidney collagen (2–5), lens crystallins (6, 7), plasma (8, 9), serum (10), urine (11), and synovial fluid (12, 13). Pentosidine is readily prepared from arginine, lysine, and a pentose (hence its name). Dyer et al. (14) have also described its formation from glucose, albeit at a slower rate and probably through oxidation of glucose to arabinose (15). Because its formation from either glucose or ribose requires oxidation, pentosidine is both an AGE and a “glycoxidation” product (16).
Structure of pentosidine.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Sell, D. R. and Monnier, V. M. (1989) Structure elucidation of a senescence crosslink from human extracellular matrix. J. Biol. Chem. 264, 21,597–21,602.
Sell, D. R. and Monnier, V. M. (1990) End-stage renal disease and diabetes catalyze the formation of a pentose-derived crosslink from aging human collagen. J. Clin. Invest. 85, 380–384.
Dyer, D. G., Dunn, J. A., Thorpe, S. R., Bailie, K. E., Lyons, T. J., McCance, D. R., and Baynes, J. W. (1993) Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J. Clin. Invest. 91, 2463–2469.
Sell, D. R., Lapolla, A., Odetti, P., Fogarty, J., and Monnier, V. M. (1992) Pentosidine formation in skin correlates with severity of complications in individuals with longstanding IDDM. Diabetes 41, 1286–1292.
Sell, D. R., Lane, M. A., Johnson, W. A., Masoro, E. J., Mock, O. B., Reiser, K. M., Fogarty, J. F., Cutler, R. G., Ingram, D. K., Roth, G. S., and Monnier, V. M. (1996) Longevity and the genetic determination of collagen glycoxidation kinetics in mammalian senescence. Proc. Natl. Acad. Sci. USA 93, 485–490.
Lyons, T. J., Silvestri, G., Dunn, J. A., Dyer, D. G., and Baynes, J. W. (1991) Role of glycation in modification of lens crystallins in diabetic and non-diabetic senile cataracts. Diabetes 40, 1010–1015.
Nagaraj, R. H., Sell, D. R., Prabhakaram, M., Ortwerth, B. J., and Monnier, V. M. (1991) High correlation between pentosidine protein crosslinks and pigmentation implicates ascorbate oxidation in human lens senescence and cataractogenesis. Proc. Natl. Acad. Sci. USA. 88, 10,257–10,261.
Odetti, P. O., Fogarty, J., Sell, D. R., and Monnier, V. M. (1992) Chromatographic uantitation of plasma and erythrocyte pentosidine in diabetic and uremic subjects. Diabetes 41, 153–159.
Taneda, S. and Monnier, V. M. (1994) ELISA of pentosidine, an advanced glycation end product, in biological specimens. Clin. Chem. 40, 1766–1773.
Takahashi, M., Kushida, K., Kawana, K., Ishihara, C., Denda, M., Inoue, T., and Horiuchi, K. (1993) Quantification of the cross-link pentosidine in serum from normal and uremic subjects. Clin. Chem. 39, 2162–2165.
Takahashi, M., Ohishi, T., Aoshima, H., Kawana, K., Kushida, K., Inoue, T., and Horiuchi, K. (1993) The Maillard protein cross-link pentosidine in urine from diabetic patients. Diabetologia 36, 664–667.
Rodriguez-Garcia, J., Requena, J. R., and Rodriguez-Segade, S. (1998) Increased concentrations of serum pentosidine in rheumatoid arthritis. Clin. Chem. 44, 250–255.
Miyata, T., Ishiguro, N., Yasuda, Y., Ito, T., Nangaku, M., Iwata, H., and Kurokawa, K. (1998) Increased pentosidine and advanced glycation end product, in plasma and synovial fluid from patients with rheumatoid arthritis and its relation with inflammatory markers. Biochem. Biophys. Res. Commun. 244, 45–49.
Dyer, D. G., Blackledge, J. A., Thorpe, S. R., and Baynes, J. W. (1991) Formation of pentosidine during nonenzymatic browning of proteins by glucose. J. Biol. Chem. 266, 11,654–11,660.
Wells-Knecht, K. J., Zyzak, D. V., Litchfield, J. E., Thorpe, S. R., and Baynes, J. W. (1995) Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose. Biochemistry 34, 3702–3709.
Baynes, J. W. (1991) Role of oxidative stress in development of complications in diabetes. Diabetes 40, 405–412.
McCance, D. R., Dyer, D. G., Dunn, J. A., Bailie, K. E., Thorpe, S. R., Baynes, J. W., and Lyons, T. J. (1993) Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus. J. Clin. Invest. 91, 2470–2478.
Takahashi, M., Suzuki, M., Kushida, K., Miyamoto, S., and Inoue, T. (1997) Relationship between pentosidine levels in serum and urine and activity in rheumatoid arthritis. B r. J. Rheumatol. 36, 637–642.
Thorpe, S. R. and Baynes, J. W. (1996) Role of the Maillard Reaction in diabetes and diseases of aging. Drugs Aging 9, 69–77.
Stegemann, H. and Stalder, K. (1967) Determination of hydroxyproline. Clin. Chim. Acta 18, 267–273.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Requena, J.R., Price, D.L., Thorpe, S.R., Baynes, J.W. (2000). Measurement of Pentosidine in Biological Samples. In: Barnett, Y.A., Barnett, C.R. (eds) Aging Methods and Protocols. Methods in Molecular Medicine, vol 38. Humana Press. https://doi.org/10.1385/1-59259-070-5:209
Download citation
DOI: https://doi.org/10.1385/1-59259-070-5:209
Publisher Name: Humana Press
Print ISBN: 978-0-89603-582-9
Online ISBN: 978-1-59259-070-4
eBook Packages: Springer Protocols